5 Key Takeaways
-
1
Patients with macular disease prioritize error rate and the presence of a second reader when considering AI in treatment decisions.
-
2
The study involved 374 participants, with 181 completing the full ranking task, focusing on AI's role in retreatment decisions.
-
3
Participants showed no significant preference for AI versus human readers, indicating a shift in focus from the reader type to reliability.
-
4
The findings suggest that successful AI adoption in macular clinics requires emphasis on performance, accuracy, and transparency.
-
5
A human making final decisions with AI support was viewed positively by participants, highlighting a potential collaborative approach.
This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.
